The psychosis analysis in real-world on a cohort of large-scale patients with schizophrenia

被引：0
作者：
Wenyan Tan
Haicheng Lin
Baoxin Lei
Aihua Ou
Zehui He
Ning Yang
Fujun Jia
Heng Weng
Tianyong Hao
机构：
[1] Guangdong Academy of Medical Science,Guangdong Mental Health Center, Guangdong Provincial People’s Hospital
[2] South China Normal University,School of Computer Science
[3] The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Department of Big Data Research of Medicine
[4] The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital),undefined
来源：
BMC Medical Informatics and Decision Making | / 20卷
关键词：
Schizophrenia; Epidemiology research; Quantitative analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis
    Rajagopalan, Krithika
    Wade, Sally
    Meyer, Nicole
    Loebel, Antony
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (05) : 813 - 820
  • [32] From Environment to Therapy in Psychosis: A Real-World Momentary Assessment Approach
    Myin-Germeys, Inez
    Birchwood, Maximillian
    Kwapil, Thomas
    SCHIZOPHRENIA BULLETIN, 2011, 37 (02) : 244 - 247
  • [33] Correlates of real-world goal-directed behavior in schizophrenia
    Merchant, Jaisal T.
    Moran, Erin K.
    Strube, Michael J.
    Barch, Deanna M.
    PSYCHOLOGICAL MEDICINE, 2023, 53 (06) : 2409 - 2417
  • [34] Altered nonlinear Granger causality interactions in the large-scale brain networks of patients with schizophrenia
    Fu, Yu
    Niu, Meng
    Gao, Yuanhang
    Dong, Shunjie
    Huang, Yanyan
    Zhang, Zhe
    Zhuo, Cheng
    JOURNAL OF NEURAL ENGINEERING, 2022, 19 (06)
  • [35] Swedish large-scale schizophrenia study: Why do patients and healthy controls participate?
    Dufva, Ylva Eriksson
    Westman, Henrietta
    Khilbom, Ulrik
    Sullivan, Patrick F.
    Johansson, Viktoria
    SCHIZOPHRENIA RESEARCH, 2021, 228 : 360 - 366
  • [36] The Optimal Length of Hospitalization for Functional Recovery of Schizophrenia Patients, a Real-World Study in Chinese People
    Bian, Yun
    Lin, Chen
    Yang, Fude
    Han, Xiaole
    Zhang, Jing
    Ma, Botao
    Zhu, Yu
    Wang, Zhixiong
    PSYCHIATRIC QUARTERLY, 2019, 90 (03) : 661 - 670
  • [37] Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder
    Citrome, Leslie
    Reist, Christopher
    Palmer, Liisa
    Montejano, Leslie B.
    Lenhart, Gregory
    Cuffel, Brian
    Harnett, James
    Sanders, Kafi N.
    SCHIZOPHRENIA RESEARCH, 2009, 115 (2-3) : 115 - 120
  • [38] Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
    Hye Ok Kim
    Gi Hyeon Seo
    Boung Chul Lee
    Annals of General Psychiatry, 19
  • [39] Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative Symptoms
    Novick, Diego
    Montgomery, William
    Treuer, Tamas
    Victoria Moneta, Maria
    Maria Haro, Josep
    PHARMACOPSYCHIATRY, 2017, 50 (02) : 56 - 63
  • [40] A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics
    He, Luyao
    Yu, Yimin
    Zhang, Lei
    He, Shen
    Yu, Wenjuan
    Li, Lujin
    Huang, Jingjing
    Li, Huafang
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (01) : 71 - 74
12345